Validation of highly selective sphingosine kinase 2 inhibitors SLM6031434 and HWG-35D as effective anti-fibrotic treatment options in a mouse model of tubulointerstitial fibrosis

Stephanie Schwalm, Sandra Beyer, Redona Hafizi, Sandra Trautmann, Gerd Geisslinger, David R. Adams, Susan Pyne, Nigel Pyne, Liliana Schaefer, Andrea Huwiler, Josef Pfeilschifter

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Validation of highly selective sphingosine kinase 2 inhibitors SLM6031434 and HWG-35D as effective anti-fibrotic treatment options in a mouse model of tubulointerstitial fibrosis'. Together they form a unique fingerprint.

Medicine & Life Sciences